Literature DB >> 12464374

Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history.

Glinda S Cooper1, Mary Anne Dooley, Edward L Treadwell, E William St Clair, Gary S Gilkeson.   

Abstract

We examined risk factors for systemic lupus erythematosus (SLE) in 265 recently diagnosed patients in North Carolina and South Carolina and 355 control subjects identified through driver's license records and frequency matched to patients by age, sex, and state. Analyses were limited to exposures before diagnosis (cases) or reference year (control subjects). SLE patients were more likely than control subjects to report a history of allergy to medications (odds ratio [OR] 3.1, 95% confidence interval [CI], 2.1-4.5), particularly to antibiotics. SLE risk increased with history of shingles (OR 2.5, 95% CI 1.1-5.9) and with frequent (more than once per year) cold sores in the 3 years before diagnosis (OR 2.8, 95% CI 1.4-5.4). There was little association with history of mononucleosis, a marker of late infection with Epstein-Barr virus, implanted medical devices, or hepatitis B vaccination. History of lupus in parents or siblings was associated with an increased risk (OR 3.3, 95% CI 1.2-8.6). Further research is needed to clarify whether medication allergies and specific infectious agents are involved in the etiology of SLE. Published by Elsevier Science Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12464374     DOI: 10.1016/s0895-4356(02)00429-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  28 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Shared autoimmunity: the time has come.

Authors:  Donato Alarcón-Segovia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 3.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses' Health Study Cohorts.

Authors:  Medha Barbhaiya; Bing Lu; Jeffrey A Sparks; Susan Malspeis; Shun-Chiao Chang; Elizabeth W Karlson; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

Review 5.  Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.

Authors:  William F Pendergraft; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Mol Med (Berl)       Date:  2004-12-11       Impact factor: 4.599

Review 6.  Lupus nephritis: an update.

Authors:  Tasnim F Imran; Frederick Yick; Suneet Verma; Christopher Estiverne; Chinonye Ogbonnaya-Odor; Srikanth Thiruvarudsothy; Alluru S Reddi; Neil Kothari
Journal:  Clin Exp Nephrol       Date:  2015-10-16       Impact factor: 2.801

Review 7.  Understanding the role of environmental factors in the development of systemic lupus erythematosus.

Authors:  Christine G Parks; Aline de Souza Espindola Santos; Medha Barbhaiya; Karen H Costenbader
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-10-21       Impact factor: 4.098

8.  The United States to Africa lupus prevalence gradient revisited.

Authors:  Gs Gilkeson; Ja James; Dl Kamen; Tj Knackstedt; Dr Maggi; Ak Meyer; Nm Ruth
Journal:  Lupus       Date:  2011-10       Impact factor: 2.911

9.  Is lipstick associated with the development of systemic lupus erythematosus (SLE)?

Authors:  Jun Wang; Ashley B Kay; Jeremiah Fletcher; Margaret K Formica; Timothy E McAlindon
Journal:  Clin Rheumatol       Date:  2008-06-04       Impact factor: 2.980

10.  Alcohol consumption is not protective for systemic lupus erythematosus.

Authors:  J Wang; A B Kay; J Fletcher; M K Formica; T E McAlindon
Journal:  Ann Rheum Dis       Date:  2008-04-13       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.